Empowering researchers with large scale supply of SPPS-compatible, orthogonally protected lanthionine building blocks.
About Us
The Tabor Group has partnered with IRIS BIOTech in optimising and scaling the production of thioether-bridged amino acids, breaking through traditional synthesis challenges to drive innovation.
Our expertise makes SPPS compatible lanthionines more accessible, empowering researchers and advancing therapeutic developments.
By delivering cutting-edge solutions, we aim to transform research in peptide field and beyond.
Sign up today and receive the latest updates
on our commercial launch.
Our Solution
Accelerate your research with our orthogonally protected lanthionine building blocks, specifically engineered for seamless compatibility with solid phase synthesis.
Seamless Integration
Transform your workflow and goals with unparalleled speed.
Faster and More Efficient Progress
High-quality solutions save up to 3 months of synthesis time.
Scalable Supply
Now available commercially in multigram quantities.
Features
SPPS Compatible:
Designed specifically for seamless integration into solid-phase peptide synthesis workflows.
Multi-gram Scale Availability:
Conveniently supplied in quantities to meet research and commercial needs.
High Quality:
Manufactured with quality control to ensure reliability and consistency.
Immediate Use:
Eliminating the need to additional preparation, saving you valuable time.
Focused on These Professionals
Custom Peptide Synthesis Suppliers
Companies that make molecules for other businesses or research labs.
Pharmaceutical Companies
Teams creating the next generation of medicines.
Academic and Industry Researchers
Scientists focused on lathionine-containing peptides and peptide-based drug discovery.
REGISTER YOUR INTEREST
Explore how our cutting-edge solutions can empower your research and drive advancements in the field.
Sign up now and stay informed about our breakthroughs.